𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytotoxic T-lymphocytes recognizing P-glycoprotein in murine multidrug-resistant leukemias

✍ Scribed by Eiichi Azuma; Shinichi Masuda; Jiang Qi; Tadashi Kumamoto; Masahiro Hirayama; Masataka Nagai; Shinya Hiratake; Masakazu Umemoto; Yoshihiro Komada; Minoru Sakurai

Book ID
114792258
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
579 KB
Volume
59
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

P202 Multidrug resistance in chronic lym
P202 Multidrug resistance in chronic lymphocytic leukemia
✍ T. Szendrei; T. Magyarlaki; G. KovΓ‘cs; Á. Szomor; Á. Nagy; L. MolnΓ‘r; M. TΓΆkΓ©s-F πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 46 KB

25/27 patients are alive, while 2 patients died before D100. 15/24 patients reached metabolic remission. All of them are in complete remission at the time of evaluation after a median follow-up time of 515 (range 342 773) days. In 2/8 PETpositive patients rebiopsy proved progression or relapse. In 1

SDZ PSC 833, A non-immunosuppressive cyc
SDZ PSC 833, A non-immunosuppressive cyclosporine: Its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia
✍ Roland P. Keller; Hans J. Altermatt; Kees Nooter; Guenter Poschmann; Jean A. Lai πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 637 KB

Cyclosporin A (CsA, Sandimmune) is known to reverse P-glycoprotein(P-gp I70)mediated multidrug resistance as efficiently as other prototype compounds of resistance modifiers. The immunosuppressive activity and nephrotoxicity of CsA, however, may limit its clinical use. PSC-833, a new cyclosporine, e